Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support in IVF
PACTR202202641392530Phase 3Not yet recruiting
- Sponsor
- Researcher
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in female infertility comparing Oral dydrogesterone with Micronized vaginal progesterone (2 arms). Primary endpoint: Presence of fetal heart beats at 12 weeks' gestation. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
dydrogesteroneprogesterone
03
Conditions
female infertility
Beyond the preview
Go deeper on PACTR202202641392530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202202641392530.